T. Barlas Et Al. , "Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.," Endocrine-related cancer , 2024
Barlas, T. Et Al. 2024. Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.. Endocrine-related cancer .
Barlas, T., Sutcuoglu, O., Akdogan, O., Balos Toruner, F. S., Akturk, M., Özdemir, N., ... Yazıcı, O.(2024). Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.. Endocrine-related cancer .
Barlas, TUĞBA Et Al. "Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.," Endocrine-related cancer , 2024
Barlas, TUĞBA Et Al. "Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.." Endocrine-related cancer , 2024
Barlas, T. Et Al. (2024) . "Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.." Endocrine-related cancer .
@article{article, author={TUĞBA BARLAS Et Al. }, title={Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center.}, journal={Endocrine-related cancer}, year=2024}